document4
TRANSCRIPT
![Page 1: Document4](https://reader036.vdocuments.pub/reader036/viewer/2022083115/58ecc65e1a28ab572c8b4633/html5/thumbnails/1.jpg)
Stefanadis C et al, J Am Col Cardiol 2001 April
ΔΤ - Percutanenous Coronary InterventionsΔΤ - Percutanenous Coronary Interventions
![Page 2: Document4](https://reader036.vdocuments.pub/reader036/viewer/2022083115/58ecc65e1a28ab572c8b4633/html5/thumbnails/2.jpg)
Coronary Thermography• Thermal heterogeneity exists in vivo in atherosclerotic plaque• Statins decrease thermal heterogeneity possibly by anti-
inflammatory mechanism• Thermal heterogeneity in the culprit lesion is a prognostic
factor for adverse cardiac events after percutaneous interventions
• Is thermal heterogeneity a sensitive marker for future cardiac events?
![Page 3: Document4](https://reader036.vdocuments.pub/reader036/viewer/2022083115/58ecc65e1a28ab572c8b4633/html5/thumbnails/3.jpg)
Primary end point: Death, MI, TLR in 12 months
Secondary end points:-Procedural complications-Cost effectiveness over 12 months
Stenting of culprit lesion only Stenting of culprit + non-culprit lesions
Randomization
Non-culprit lesion(s) with > 0.10OC T
Patients with ACS and multivessel disease
THERMO ACS: Culprit or Multivessel Revascularization based on
Thermography in patients with ACS
![Page 4: Document4](https://reader036.vdocuments.pub/reader036/viewer/2022083115/58ecc65e1a28ab572c8b4633/html5/thumbnails/4.jpg)
… … Thermography Beyond Coronary ArteriesThermography Beyond Coronary Arteries